Biotechnology company Cassava Sciences (NASDAQ:SAVA) has only two primary product candidates, but they’re highly significant. SAVA stock holders, like all biotech-sector investors, should stay informed on all clinical developments as they’re likely to influence the share price. Source: Shutterstock Cassava Sciences shares are particularly sensitive to news-related events. That’s not a bad thing, though, as the
0 Comments
AT&T (NYSE:T) shocked the world this summer. AT&T has long been a centerpiece of many retirees and income investors’ portfolios. T stock generally yielded in the 6% range annually, and at times paid an even higher rate than that. Source: Jonathan Weiss/Shutterstock This was a massive number in a zero interest rate world. With banks paying
0 Comments
Meta Materials (NASDAQ:MMAT) is a Canadian company that recently listed on the Nasdaq via a SPAC (special purpose acquisition corporation) reverse merger. To put it bluntly, MMAT stock is the kind of highly speculative stock you ought to avoid. Source: Shutterstock This high-tech company develops nanocomposite materials and products. The debt-free company announced it had closed
0 Comments
In a matter of weeks, DiDi Global (NYSE:DIDI) stock has gone from a hot IPO to an undeniable disaster. Soon after its debut on the U.S. stock market at an initial price of $14 per share, the China-based ride-hailing company was hit hard by the  Chinese government’s decision to investigate and penalize it. The shares
0 Comments
With the worrying volatility of cryptocurrencies since their April and May highs of this year, it’s not just digital asset speculators that are concerned. In addition, companies that benefit from blockchain bullishness, particularly graphics processor manufacturers like Nvidia (NASDAQ:NVDA) may encounter some choppiness down the line. Indeed, NVDA stock has already printed some hefty red-ink
0 Comments